ADAGES III: Contribution of Genotype to Glaucoma Phenotype in African Americans
Weinreb Robert N., M.D.
NIH / NEI
African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the Lamina Cribrosa in Progression
Zangwill Linda M., Ph.D.
NIH
Age-Related Alterations in 5-Hydroxymethyl Cytidine Levels and Their Impact on Human Physiology
Skowronska-Krawczyk, Dorota, M.Sc., Ph.D.
Center for Healthy Aging, UC San Diego
Center for Healthy Aging Research Pilot Award
Characterization of the Role of Dual Leucine Zipper Kinase (DLK) in Structural and Functional Retinal Ganglion Cell Loss in Rodent Models of Optic Neuropathy
Welsbie Derek S., M.D., Ph.D.
Fight For Sight Foundation
Collaboration on the Development of an Inhibitor of Dual Leucine Zipper Kinase (DLK) and Leucine Zipper Kinase Consortium
Welsbie Derek S., M.D., Ph.D.
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
Weinreb Robert N., M.D.
NIH / NEI
Diagnostic Innovations in Glaucoma Study (DIGS): High Myopia and Advanced Diseases
Zangwill Linda M., Ph.D.
NIH
Dietary Interventions to Improve Vision UC San Diego
Zangwill Linda M., Ph.D.
Krupp Endowment Fund (KEF) Research Awards
Effects of a Single Osteopathic Manipulative Treatment (OMT) in Intraocular Pressure (IOP)
Zangwill Linda M., Ph.D.
Eliminate to Protect
Skowronska-Krawczyk Dorota, M.Sc., Ph.D.
Glaucoma Research Foundation
Glaucoma Neuroprotection: Rho-Associated Kinase 2 (ROCK2) as an Upstream Activator of Dual-Leucine Zipper Kinase (DLK) in Response to Axonal Injury
Welsbie Derek S., M.D., Ph.D.
Ziegler Foundation Career Development Award
Kinase Multitargeting for Glaucoma Neuroprotection
Welsbie Derek S., M.D., Ph.D.
NIH
Machine Learning Methods for Detecting Disease-Related Functional and Structural Change in Glaucoma
Bowd Christopher, Ph.D.
NIH
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy
Ju Wonkyu, Ph.D.
NIH
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy
Ju Wonkyu, Ph.D.
UC San Diego Academic Senate
Molecular Mechanism of Glaucoma
Skowronska-Krawczyk Dorota, M.Sc. Ph.D.
NIH
Nanoparticle-Based Glaucoma-Targeted Gene Therapy: A New Look at the Therapy for People who are Losing their Sight Ability
Skowronska-Krawczyk Dorota, M.Sc.
Ph.D. Eppley Foundation
Novel AAV/CRISPR Therapeutic for DLK Inhibition
Welsbie Derek S., M.D., Ph.D.
Brightfocus Foundation Glaucoma Research Award
Ocular Hypertension Treatment Study 20-Year Follow-Up: Clinic Center
Weinreb Robert N., M.D.
NIH / NEI
Ocular Hypertension Treatment Study 20-Year Follow-Up: Resource Center For The UC San Diego Optical Coherence Tomography Reading Center
Zangwill Linda M., Ph.D.
NIH
Ophthalmology and Visual Sciences Career Development K12 Program
Weinreb Robert N., M.D.
NIH / NEI
Optical Coherence Tomography in the Ocular Hypertension Treatment Study
Zangwill Linda M., Ph.D.
Zeiss
Personalized Forecasting of Disease Trajectory for Patients with Open Angle Glaucoma
Zangwill Linda M., Ph.D.
NIH
Targeting Dual Leucine Zipper Kinase as a Therapeutic Strategy for Traumatic Optic Neuropathy and Brain Injury
Welsbie Derek S., M.D., Ph.D.
Department of Defense Vision Research Program Translational Research Award
The Role of Microvasculature in the Pathophysiology of Glaucoma
Zangwill Linda M., Ph.D.
Brightfocus Foundation
Understanding Senescence to Develop Glaucoma Treatments